Abstracts Archive - Page 392 of 1683 - ATC Abstracts

2020 American Transplant Congress
Potential Cost-Savings Associated with ANG-3777 for the Treatment of Delayed Graft Function in Kidney Transplantation
M. Cooper¹, T. Mayne², T. Kauf³, M. Gargano³, K. Freemyer³
¹Medstar Georgetown Transplant Institute, Washington, DC, ²Angion Biomedica Corp, San Francisco, CA, ³Genesis Research, Hoboken, NJ
*Purpose: We created a medical cost offset model based upon the results of a Phase 2, double-blind, randomized controlled trial of ANG-3777, a hepatocyte growth…
2020 American Transplant Congress
Sequence Variations of the LMP1 Protein are Detected in Pediatric Transplant Recipients and May Increase the Risk of EBV Disease
B. Mbiribindi¹, M. Arvedson¹, J. Pena¹, O. Hatton², C. Esquivel¹, O. Martinez¹, S. Krams¹
¹Department of Surgery/Division of Abdominal Transplantation, Stanford Univ School of Med, Stanford, CA, ²Molecular Biology, Colorado College, Colorado Springs, CO
*Purpose: Epstein-Barr virus (EBV) infects more than 90% of adults worldwide and is associated with several malignancies, including post-transplant lymphoproliferative disorder (PTLD). PTLD is a…
2020 American Transplant Congress
Association between Ezetimibe Usage and Hepatitis C RNA Levels in Uninfected Kidney Transplant Recipients Who Received Hepatitis C Infected Kidneys
A. Azhar, M. Yazawa, M. Talwar, V. Balaraman, A. Bhalla, U. A. Agbim, B. Maliakkal, J. P. Kothadia, S. Nair, J. D. Eason, M. Z. Molnar
James D. Eason Transplant Institute, Methodist University Hospital, Memphis, TN
*Purpose: Our previous data showed that transplantation of kidneys from hepatitis C virus (HCV) infected donors to HCV negative recipients achieved excellent short-term graft function,…
2020 American Transplant Congress
The Use of Interviews to Explore the Public Attitudes on the Use of Imminent Death Donation
P. Moolchandani¹, L. Washburn¹, M. Goss², S. Parsons³, R. Brown³, E. Ranova³, R. Ackah¹, K. Myer⁴, R. Wood⁴, A. Rana¹, J. Goss¹, T. Galván¹
¹Division of Abdominal Transplantation, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, ²University of Houston College of Medicine, Houston, TX, ³Rice University, Houston, TX, ⁴LifeGift, Houston, TX
*Purpose: Imminent death donation (IDD) describes non-fatal recovery of a living donor organ (a single kidney or partial liver) prior to a planned withdrawal of…
2020 American Transplant Congress
The Importance of Annual Medicare Part D Plan Evaluation
L. Potter¹, E. Garrity²
¹Department of Pharmacy, University of Chicago Medicine, Chicago, IL, ²Transplant Institute, University of Chicago Medicine, Chicago, IL
*Purpose: The Medicare open enrollment period is from Oct 15 to Dec 7, annually. The purpose of this project was to objectively measure the benefit…
2020 American Transplant Congress
Lifetime Survival Estimates Following Solid Organ Transplantation in the United States
C. Graham¹, M. Skeans², Y. Ahn², C. Watson³, A. Barlev⁴
¹RTI Health Solutions, Research Triangle Park, NC, ²Chronic Disease Research Group, Minneapolis, MN, ³Atara Biotherapeutics, South San Francisco, CA, ⁴Atara Biotherapeutics, Thousand Oaks, CA
*Purpose: The Scientific Registry of Transplant Recipients (SRTR) contains detailed patient and graft survival data for all solid organ transplants (SOT) in the United States…
2020 American Transplant Congress
Implicit Bias in Recipient Selection
Y. Sweidan¹, C. Mayuga¹, B. Daly¹, K. Chavin², T. Srinivas¹, A. Padiyar¹
¹Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, ²Surgery, University Hospitals Cleveland Medical Center, Cleveland, OH
*Purpose: The decision to place or exclude a candidate from the waitlist is not exclusively based on medical criteria. Scant literature exists regarding the intergroup…
2020 American Transplant Congress
The Role and Impact of Transplant Pharmacist Evaluation in a Pre-Kidney Transplant Clinic
B. Valdepenas, D. Choi, J. Benken, M. Campara
Pharmacy Practice and Transplant Surgery, University of Illinois at Chicago, Chicago, IL
*Purpose: The Centers for Medicare and Medicaid Services’ interpretative guidelines for conditions of participation for transplant centers define the transplant pharmacist’s role ambiguously. Limited evidence…
2020 American Transplant Congress
Impact of Patients’ Perception of Hospital Experience on Organ Donation Rates
A. Azim¹, A. Friedman², S. Nishida¹, K. Okumura¹, G. Veillette¹, T. Diflo¹, R. Latifi¹, H. Sogawa¹
¹Surgery, Westchester Medical Center, Valhalla, NY, ²Transplant, Live On NY, New York, NY
*Purpose: The Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey is a validated data collection methodology for measuring a patient’s perception of his/her…
2020 American Transplant Congress
Next-Generation Sequencing to Assess Cytomegalovirus Viral Populations During the Course of CMV Infection
G. Elhelou¹, R. Razonable²
¹Medicine, Division of Infectious Diseases and Global Medicine, University of Florida, Gainesville, FL, ²Medicine, Division of Infectious Disease, Mayo Clinic, Rochester, MN
*Purpose: Resistant Cytomegalovirus (CMV) infection has emerged to cause significant impact on morbidity and mortality after solid organ transplantation (SOT). There is limited data on…